NVO position history
The shares of Novo Nordisk (NVO) that Kentucky Trust Co reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q4: 5,750 shares, $495K, 0.29% of portfolio
- 2025 Q1: 5,650 shares, $392K, 0.23% of portfolio, Reduce −1.7%
- 2025 Q2: 5,650 shares, $390K, 0.22% of portfolio
- 2025 Q3: 5,650 shares, $314K, 0.17% of portfolio
- 2025 Q4: 5,250 shares, $267K, 0.14% of portfolio, Reduce −7.1%
- 2026 Q1: 5,250 shares, $193K, 0.10% of portfolio
- 2026 Q2: 5,250 shares, $252K, 0.12% of portfolio
- 2026 Q3: 5,250 shares, $199K, 0.10% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|